COA available
Metabolic Research//30mg
TZ
$285.00
Research-grade peptide material for laboratory investigation of receptor pharmacology and related molecular pathways.
BT Labs report available for a Peptide Underground Group sample. This does not confirm the current Veridian product lot was tested.
Third-party laboratory report
Batch No.
P1002
Purity
99.7%
Test Date
2026-10-01
Submitted by Peptide Underground Group. Results apply to the lab sample, not automatically to Veridian inventory.
View COATechnical Dossier
Batch / Lot Number
—
Testing Status
Pending
Testing Laboratory
BT Labs
Test Date
2026-10-01
Research Information
For laboratory research only. Retatrutide: investigational peptide studied for GIP, GLP-1, and glucagon receptor pharmacology. Tirzepatide: synthetic peptide studied for GIP and GLP-1 receptor pharmacology. Published human clinical findings concern specific research or approved pharmaceutical contexts and are not claims about Veridian's research-grade material. Not for human consumption or therapeutic use.
Available Documentation
- Certificate of Analysis View COA
